It was hypothesized that the feature of transforming the protein signal into an amplifiable signal could overcome the lack of sensitivity associated with the classical ELISA approach and thereby facilitate the use of survivin as a biomarker for bladder cancer detection. The gene discussed is BIRC5; the disease is urinary bladder cancer.